Sperm DNA Fragmentation Index (DFI)

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 14, 2026

Sperm DNA Fragmentation Index (DFI) is a measure of the proportion of sperm with damaged or broken DNA strands. Standard semen analysis evaluates sperm count, motility, and morphology. It does not assess DNA integrity. A semen sample can appear normal on standard analysis while carrying a high burden of DNA strand breaks.¹

Elevated DFI associates with reduced natural conception rates, higher miscarriage risk, and impaired embryo development.² The threshold commonly cited in the literature is a DFI above 15 to 25%, depending on the assay used. Above that range, fertility outcomes decline measurably.¹

Three assays are in common use: TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling), SCSA (Sperm Chromatin Structure Assay), and the COMET assay. Each measures DNA strand breaks by a different mechanism. Results are not always interchangeable across assays. The clinical report should specify which assay was used.³

The correctable causes of elevated DFI include oxidative stress, varicocele, infection, heat exposure, and certain medications. When a correctable cause is identified, addressing it directly often reduces DFI and improves outcomes. Antioxidant therapy is frequently studied as a supportive measure. Varicocele repair, when clinically indicated, can reduce DFI and improve sperm parameters.²³

DFI testing is most clinically relevant in unexplained infertility, recurrent pregnancy loss, and cases where standard semen parameters appear normal but the couple has not conceived. The male factor contributes to fertility outcomes in the majority of couples, and DNA integrity is one dimension of male fertility that standard analysis leaves unevaluated.¹⁴

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.